Trials / Completed
CompletedNCT00427505
Study to Investigate the Effect of Deferasirox on the Pharmacokinetics of Midazolam
An Open-label, One-sequence Cross-over Study to Investigate the Effect of Deferasirox on the Pharmacokinetics of Midazolam in Healthy Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 22 (planned)
- Sponsor
- Novartis · Industry
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
This is a study to investigate the pharmacokinetics of deferasirox
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Deferasirox |
Timeline
- Start date
- 2006-07-01
- First posted
- 2007-01-29
- Last updated
- 2009-11-19
Source: ClinicalTrials.gov record NCT00427505. Inclusion in this directory is not an endorsement.